Filing Details

Accession Number:
0001104659-16-164625
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-12-30 18:07:37
Reporting Period:
2016-12-28
Filing Date:
2016-12-30
Accepted Time:
2016-12-30 18:07:37
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1453687 Selecta Biosciences Inc SELB Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1676930 Kei Takashi Kishimoto C/O Selecta Biosciences, Inc.
480 Arsenal Way
Watertown MA 02472
Chief Scientific Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-12-28 10,000 $2.77 10,000 No 4 M Direct
Common Stock Disposition 2016-12-28 10,000 $17.55 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (right to buy) Disposition 2016-12-28 10,000 $0.00 10,000 $2.77
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
79,743 2021-09-07 No 4 M Direct
Footnotes
  1. The shares underlying the option are fully vested.